FAST-BOLUS

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

8 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

This study measures plasma biomarkers in children enrolled in PRoMPT BOLUS with existing stored samples which were collected at randomization in order to assess the for differential effects of fluid assignment on MAKE30 across risk strata using two distinct biomarker-based mortality prediction models (Aim 1) and separately across two different biomarker-defined inflammatory sub-phenotypes (Aim 2). The study will also leverage this biobank to investigate potential mechanisms between fluid choice and MAKE30 by measuring markers of endothelial cell and endothelial glycocalyx damage (Aim 3).

Eligibility & Criteria

IRB #:
21-019471
Official Title:
Finding Appropriate Subtypes in a Trial of Balanced versus nOrmaL Saline FlUid in Sepsis
Study Phase:
Not Applicable
Eligible Age Range:
6 Months - 17 Years
Gender:
All
Study Categories:
Leader
Nadir Yehya

Nadir Yehya, MD